For people with mild hyper-tension, encouraging lifestyle changes should be the first line of recommendations for physicians rather than putting them on drugs, suggest experts.
Lead researcher Stephen Martin and colleagues argue that the current strategy is failing patients and wasting healthcare resources.
"Over-emphasis on drug treatment risks adverse effects such as increased risk of falls and misses opportunities to modify individual lifestyle choices," they noted.
They called for a re-examination of the threshold and urge clinicians to be cautious about treating low risk patients with blood pressure lowering drugs.
Up to 40 percent of adults worldwide have hyper-tension, over half of which is classified as mild.
Low risk indicates that an individual does not have existing cardio-vascular diseases, diabetes or kidney diseases.
Over the years, hyper-tension has been treated with drugs at progressively lower blood pressures.
"We urge clinicians to share the uncertainty surrounding drug treatment of mild hypertension with patients, measure blood pressure at home, improve accuracy of clinic measurements and encourage lifestyle changes," Martin concluded.
They were scheduled to discuss the findings at the 2014 Preventing Overdiagnosis Conference hosted by the Centre for Evidence-based Medicine at the University of Oxford.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
